Trial Profile
A prospective ,single arm, open study of Mesylate Apatinib combined with FOLFOX in the treatment of advanced colorectal cancer
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 26 Feb 2018
Price :
$35
*
At a glance
- Drugs Rivoceranib (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Colorectal cancer; Liver metastases
- Focus Adverse reactions; Therapeutic Use
- 26 Feb 2018 New trial record